| Income Statement for Vion Pharmaceuticals Inc. (VION) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 66 | 22 | 23 | 275 | 375 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 1,427 | 212 | 226 | 213 | 195 | | Gross Operating Profit | 1,493 | 234 | 249 | 488 | 570 | | | Selling/General/Admin Expense | (8,429) | (5,787) | (3,239) | (2,969) | (2,563) | | Research & Development | (24,198) | (21,484) | (16,605) | (13,807) | (9,735) | | EBITDA | (31,134) | (27,037) | (19,595) | (16,288) | (11,728) | | Depreciation & Amortization | (1,427) | (212) | (226) | (213) | (195) | | EBIT | (32,561) | (27,249) | (19,821) | (16,501) | (11,923) | | Interest Income | 3,390 | 1,994 | 1,828 | 547 | 136 | | Other Income, Net | (30) | (50) | (4) | (73) | (45) | | Total Income Avail For Interest Expense | (29,201) | (25,305) | (17,997) | (16,027) | (11,832) | | Interest Expense | (5,135) | - | (4) | - | (2) | | Pre-Tax Income | (34,336) | (25,305) | (18,001) | (16,027) | (11,834) | | Income Taxes | 343 | (42) | (40) | (28) | (4) | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (33,993) | (25,347) | (18,041) | (16,055) | (11,838) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (33,993) | (25,347) | (18,041) | (16,055) | (11,838) | | | Normalized Income | (33,993) | (25,347) | (18,041) | (16,055) | (11,838) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (33,993) | (25,347) | (18,041) | (16,055) | (11,838) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -5.05 | -3.80 | -2.80 | -3.00 | -3.60 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -5.05 | -3.80 | -2.80 | -3.00 | -3.60 | | | Diluted EPS from Continuing Operations | -5.05 | -3.80 | -2.80 | -3.00 | -3.60 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -5.05 | -3.80 | -2.80 | -3.00 | -3.60 | | | |
